Jpmorgan Chase & CO Stealth Bio Therapeutics Corp Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$0.49 - $0.9 $98 - $180
-201 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$0.76 - $1.48 $152 - $297
201 New
201 $0

Others Institutions Holding MITO

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About Stealth BioTherapeutics Corp

MITO Quotes by TradingView
  • Ticker MITO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,548,600
  • Description
  • Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duche...
More about MITO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email